Table 1.

Results for rs2286885 in the discovery and replication studies

CohortNumber of subjectsaFrequencybβbSEP-value
TwinsUK (discovery study)27720.550.560.1013.48 × 10−8
BATS11520.530.1470.130.2602
BMES16670.550.03840.0990.6994
ERF25890.570.0640.0890.476
Framingham24550.540.0900.0910.327
GHS127270.560.1360.0780.081
GHS211300.55−0.0200.1130.858
ORCADES4740.540.3580.1840.051
RSIII20340.570.0570.0920.537
RSII21160.560.0660.0940.483
RSI57820.570.1010.0620.106
Southampton1660.550.0420.4920.932
TEST6630.530.0100.1940.960
CohortNumber of subjectsaFrequencybβbSEP-value
TwinsUK (discovery study)27720.550.560.1013.48 × 10−8
BATS11520.530.1470.130.2602
BMES16670.550.03840.0990.6994
ERF25890.570.0640.0890.476
Framingham24550.540.0900.0910.327
GHS127270.560.1360.0780.081
GHS211300.55−0.0200.1130.858
ORCADES4740.540.3580.1840.051
RSIII20340.570.0570.0920.537
RSII21160.560.0660.0940.483
RSI57820.570.1010.0620.106
Southampton1660.550.0420.4920.932
TEST6630.530.0100.1940.960

BATS, Brisbane Adolescent Twin Study; BMES, Blue Mountains Eye Study; ERF, Erasmus Rucphen Family Study; GHS, Guttenberg Health Study; ORCADES, Orkney Complex Disease Study; RS, Rotterdam Study; TEST, Tasmanian Eye Study of Twins; SE, dtandard error.

aNumber of subjects refers to those with genotype information for rs2286885.

bFrequency and beta refer to the frequency and the effect size respectively for the A allele of rs2286885.

Table 1.

Results for rs2286885 in the discovery and replication studies

CohortNumber of subjectsaFrequencybβbSEP-value
TwinsUK (discovery study)27720.550.560.1013.48 × 10−8
BATS11520.530.1470.130.2602
BMES16670.550.03840.0990.6994
ERF25890.570.0640.0890.476
Framingham24550.540.0900.0910.327
GHS127270.560.1360.0780.081
GHS211300.55−0.0200.1130.858
ORCADES4740.540.3580.1840.051
RSIII20340.570.0570.0920.537
RSII21160.560.0660.0940.483
RSI57820.570.1010.0620.106
Southampton1660.550.0420.4920.932
TEST6630.530.0100.1940.960
CohortNumber of subjectsaFrequencybβbSEP-value
TwinsUK (discovery study)27720.550.560.1013.48 × 10−8
BATS11520.530.1470.130.2602
BMES16670.550.03840.0990.6994
ERF25890.570.0640.0890.476
Framingham24550.540.0900.0910.327
GHS127270.560.1360.0780.081
GHS211300.55−0.0200.1130.858
ORCADES4740.540.3580.1840.051
RSIII20340.570.0570.0920.537
RSII21160.560.0660.0940.483
RSI57820.570.1010.0620.106
Southampton1660.550.0420.4920.932
TEST6630.530.0100.1940.960

BATS, Brisbane Adolescent Twin Study; BMES, Blue Mountains Eye Study; ERF, Erasmus Rucphen Family Study; GHS, Guttenberg Health Study; ORCADES, Orkney Complex Disease Study; RS, Rotterdam Study; TEST, Tasmanian Eye Study of Twins; SE, dtandard error.

aNumber of subjects refers to those with genotype information for rs2286885.

bFrequency and beta refer to the frequency and the effect size respectively for the A allele of rs2286885.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close